Thursday, April 25, 2024
HomeOther'sHealthUzbekistan's cough syrup deaths, Congress demands action

Uzbekistan’s cough syrup deaths, Congress demands action

The Congress on Thursday slammed the Centre and demanded the “strictest” action against the Uzbekistan government’s claim that 18 children died in the Central Asian nation after consuming cough syrup made by an Indian manufacturer.

Taking to Twitter, Congress General Secretary Jairam Ramesh said: “Made in India cough syrups seem to be deadly. First, it was the deaths of 70 kids in Gambia & now it is that of 18 children in Uzbekistan. Modi Sarkar must stop boasting about India being a pharmacy to the world & take the strictest action.”

In a statement, the Uzbek Health Ministry said that “18 out of 21 children with acute respiratory disease have died as a result of taking Doc-1 Max syrup manufactured by the Indian company Marion Biotech Pvt Ltd”.

Also Read: 195 kg ganja and 5,400 banned cough syrup bottles seized in Bengal

The Ministry further alleged that the victims “took this drug at home for 2-7 days 3-4 times a day, 2.5-5 ml, which exceeds the standard dose of the drug for children” before they were hospitalized.

The Centre is yet to respond to the allegation. In October, the World Health Organization (WHO) issued an alert for four “contaminated” India-made medicines, chiefly for pediatric use, identified in the west African nation of The Gambia and found to contain chemicals that were toxic and potentially fatal after 66 child deaths.

The four medicines — cough and cold syrups — were produced by the Haryana-based Maiden Pharmaceuticals Limited.

 

 

 

(This story has been sourced from a third-party syndicated feed, agencies. Raavi Media accepts no responsibility or liability for the text’s dependability, trustworthiness, reliability, and data. Raavi Media management/ythisnews.com reserves the sole right to alter, delete or remove (without notice) the content at its absolute discretion for any reason whatsoever.)